首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

2078887

大腸桿菌菌株市場：按菌株類型、應用、致病性、最終用戶和地區分類。

Escherichia Coli Strain Market, By Strain Type, By Application, By Pathogenicity, By End User, By Geography

出版日期: 2026年04月29日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，大腸桿菌菌株市場規模將達到 24.2 億美元，到 2033 年將達到 39.1 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 7.1%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	24.2億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	7.10%	2033年市場規模預測：	39.1億美元

大腸桿菌（通常簡稱為E. coli）是一種細菌，因其多樣化的特性和在研究領域的廣泛應用而備受科學界關注。這種細菌屬於腸桿菌科，通常存在於人和動物的消化道中。雖然大腸桿菌是眾所周知的食物中毒和感染疾病的病原體，但值得注意的是，並非所有菌株都有害。事實上，許多菌株是有益的，在消化器官系統中發揮至關重要的作用，例如幫助食物分解和營養吸收。這些有益菌株也有助於維持健康的腸道菌叢，這對整體健康至關重要。然而，某些大腸桿菌菌株具有致病性，可引起多種疾病，從輕微的胃腸道不適到尿道感染、肺炎，甚至危及生命的溶血性尿毒症候群。大腸桿菌廣泛的致病潛力使其成為一個重要的公共衛生議題。由於其多方面的特性以及在健康和疾病中發揮的重要作用，大腸桿菌是科學研究中極其重要的模式生物。遺傳學、生物化學和生物技術領域對大腸桿菌的研究十分廣泛，大大增進了我們對這些學科的理解。研究人員利用大腸桿菌研究細菌遺傳學、闡明代謝途徑並開發新的生物技術應用。這些廣泛的研究不僅加深了我們對大腸桿菌本身的認知，也為更廣泛的生物學過程提供了寶貴的見解。

市場動態：

預計在預測期內，生物技術研發、重組蛋白生產和藥物開發將推動全球大腸桿菌菌株市場的成長。此外，工業生產過程預計也將促進全球大腸桿菌菌株市場的成長。生物製藥生產、合成生物學、個人化醫療和生物修復預計也將為全球大腸桿菌菌株市場帶來成長機會。

然而，安全和生物安全問題、監管障礙、與其他微生物的競爭以及污染和交叉污染的風險預計將在預測期內阻礙大腸桿菌菌株市場的成長。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球大腸桿菌菌株市場主要參與者的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球大腸桿菌菌株市場報告的目標受群眾外包括行業內的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用分析全球大腸桿菌菌株市場中使用的各種策略矩陣來簡化決策過程。

市場動態
- 促進因素
  - 在整個預測期內，生物技術研究可望推動市場成長。
- 抑制因子
  - 預計安全和生物安全問題將在預測期內阻礙市場成長。
- 機會
  - 個人化醫療，即提供客製化的大腸桿菌菌株用於精準醫療應用，預計將帶來市場機會。
主要亮點
監管趨勢
近期趨勢
產品上市及核准
PEST分析
波特的分析
併購和合作

第4章：大腸桿菌菌株市場：依菌株類型分類，2021-2033年

共生菌株
引起腹瀉的菌株
腸外致病菌株
泌尿道致病菌株
新生兒腦膜炎雙球菌菌株
其他

第5章大腸桿菌菌株市場：依應用領域分類，2021-2033年

診斷
研究
治療
重組蛋白生產
用於品管的微生物
其他

第6章大腸桿菌菌株市場：依致病性分類，2021-2033年

致病性大腸桿菌
非致病性大腸桿菌

第7章：大腸桿菌菌株市場：依最終用戶分類，2021-2033年

研究機構
診斷檢查室
製藥和生物技術公司
受託研究機構
其他

第8章：大腸桿菌菌株市場：依地區分類，2021-2033年

北美洲
歐洲
亞太地區
拉丁美洲
中東
非洲

第9章競爭情勢

公司簡介
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Novozymes A/S
- QIAGEN NV
- Promega Corporation
- Agilent Technologies, Inc.
- New England Biolabs, Inc.
- Takara Bio Inc.
- Bio-Rad Laboratories, Inc.
- GenScript Biotech Corporation
- Sanofi
- Xiamen Innovax Biotech Co., Ltd
分析師意見

第10章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI6132

Escherichia Coli Strain Market is estimated to be valued at USD 2.42 Bn in 2026 and is expected to reach USD 3.91 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.1% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 2.42 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	7.10%	2033 Value Projection:	USD 3.91 Bn

Escherichia Coli, commonly known as E. coli, is a strain of bacteria that has garnered significant scientific interest due to its diverse nature and extensive use in research. This bacterium belongs to the Enterobacteriaceae family and is typically found in the gastrointestinal tract of humans and animals. While E. coli is often associated with foodborne illnesses and infections, it's important to note that not all strains are harmful. In fact, many strains are beneficial and play a crucial role in the digestive system, aiding in the breakdown of food and absorption of nutrients. These beneficial strains also help in maintaining a healthy gut flora, which is essential for overall health.However, there are certain strains of E. coli that are pathogenic and can cause a range of illnesses, from minor gastrointestinal upset to severe conditions like urinary tract infections, pneumonia, and even life-threatening hemolytic uremic syndrome. The ability of E. coli to cause such a wide spectrum of diseases makes it a significant public health concern. E. coli's versatile nature and its role in both health and disease have made it a crucial model organism for scientific research. It is extensively studied in the fields of genetics, biochemistry, and biotechnology, contributing significantly to our understanding of these areas. Researchers use E. coli to study bacterial genetics, investigate metabolic pathways, and develop new biotechnological applications. This extensive research has not only enhanced our knowledge of E. coli itself but also provided valuable insights into broader biological processes.

Market Dynamics:

Biotechnology research, recombinant protein production and pharmaceutical development are anticipated to drive the growth of the global escherichia coli strain market over the forecast period. Moreover, industrial processes are also expected to boost the growth of the global escherichia coli strain market over the forecast period. Biopharmaceutical production, synthetic biology, personalized medicine, and bioremediation are expected to create growth opportunities for the global Escherichia Coli Strain market during the forecast period.

However, safety and biosecurity concerns, regulatory hurdles, competition from other microorganisms and contamination and cross-contamination risks are expected to hamper growth of the escherichia coli strain market over the forecast period.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global escherichia coli strain market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Novozymes A/S, QIAGEN N.V., Promega Corporation, Agilent Technologies, Inc., New England Biolabs, Inc., Takara Bio Inc., Bio-Rad Laboratories, Inc., GenScript Biotech Corporation, Sanofi, and Xiamen Innovax Biotech Co., Ltd
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global escherichia coli strain market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global escherichia coli strain market

Detailed Segmentation:

Escherichia Coli Strain Market Segmentation, By Strain Type (Revenue, USD Bn, 2021 - 2033)
Commensal strains
Diarrheal strains
Extraintestinal pathogenic strains
Uropathogenic strains
Neonatal meningitis strains
Others
Escherichia Coli Strain Market Segmentation, By Application (Revenue, USD Bn, 2021 - 2033)
Diagnostics
Research
Therapeutics
Production of recombinant proteins
Quality control organisms
Others
Escherichia Coli Strain Market Segmentation, By Pathogenicity (Revenue, USD Bn, 2021 - 2033)
Pathogenic E. coli
Non-pathogenic E. coli
Escherichia Coli Strain Market Segmentation, By End User (Revenue, USD Bn, 2021 - 2033)
Research Institutes
Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Others
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Top Companies in Escherichia Coili Strain Market:
Thermo Fisher Scientific Inc.
Merck KGaA
Novozymes A/S
QIAGEN N.V.
Promega Corporation
Agilent Technologies, Inc.
New England Biolabs, Inc.
Takara Bio Inc.
Bio-Rad Laboratories, Inc.
GenScript Biotech Corporation
Sanofi
Xiamen Innovax Biotech Co., Ltd

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Strain Type
- Market Snippet, By Application
- Market Snippet, By Pathogenicity
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
  - Biotechnology research is expected to drive the market growth over forecast period
- Restraints
  - Safety and biosecurity concerns is expected to hinder the market growth over forecast period
- Opportunities
  - Personalized medicine to provide custom-made E. coli strains for precision medicine applications is expected to provide market opportunity
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, and Collaborations

4. Escherichia Coli Strain Market, By Strain Type, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Commensal strains
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Diarrheal strains
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Extraintestinal pathogenic strains
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Uropathogenic strains
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Neonatal meningitis strains
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

5. Escherichia Coli Strain Market, By Application, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Production of recombinant proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Quality control organisms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

6. Escherichia Coli Strain Market, By Pathogenicity, 22021-2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%) Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Pathogenic E. coli
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Non-pathogenic E. coli
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

7. Escherichia Coli Strain Market, By End User, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

8. Escherichia Coli Strain Market, By Geography, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022 -2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profile
- Thermo Fisher Scientific Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Merck KGaA
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Novozymes A/S
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- QIAGEN N.V.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Promega Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Agilent Technologies, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- New England Biolabs, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Takara Bio Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Bio-Rad Laboratories, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- GenScript Biotech Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Xiamen Innovax Biotech Co., Ltd
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
Analyst Views

10. Section

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

大腸桿菌線上分析儀市場：全球市場預測，2026-2032年

大腸桿菌檢測市場規模、佔有率、趨勢和預測：按產品類型、檢測類型、最終用戶和地區分類，2026-2034 年

全球大腸桿菌檢測市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

全球大腸桿菌檢測市場（2024-2028）

FAQ

大腸桿菌菌株市場：按菌株類型、應用、致病性、最終用戶和地區分類。